GLP-1 Receptor agonist was proved by the Action Control Cardiovascular Risk in Diabetes trial (ACCORD) 75% decrease death rate in patients under Exentide treatment
EE and substrate oxidation rates In the respiratory chamber, all treatment groups had a slightly negative 24-h energy balance (mean 4.6 to 2.8%), which reached statistical significance for liraglutide 1.8 mg versus placebo (Supplementary Table 2), although energy balance for all participants was within an acceptable 10% limit (range 10.0 to 6.2%)
The evidence the brand publishes consists of in-house customer surveys, which is a long way from a randomised controlled trial
316H920H933
Muscle lactate buildup is a limiting factor that inhibits performance and causes muscle pain, meaning that if you produce less of it and are able to clear it faster, you will have a faster recovery
North America leads due to robust healthcare systems, early adoption, and reimbursement strength